Is unclassifiable idiopathic interstitial pneumonia a result of idiopathic pleuroparenchymal fibroelastosis?
Publication date: Available online 8 April 2020Source: Respiratory InvestigationAuthor(s): Hiroyoshi Yamauchi, Masashi Bando, Aya Shinozaki-Ushiku, Takashi Ogura, Tamiko Takemura, Masaaki Sato, Koichi Hagiwara
Conclusions: Short-term results indicate that MCGR may be a good option in SMA-associated collapsing spine deformity to reduce the burden of repetitive lengthening procedures. The authors recommend apical deformity control in the convex side in case of curve rigidity. In addition, including the pelvis in the instrumentation at index surgery is critical to prevent distal adding-on. Level of Evidence: Level IV—retrospective case series.
Conclusion. The spontaneous incidence rate of vertebral body infection among OVF patients was 0.7%; however, the occurrence of this complication led to serious events. Clinicians should pay attention to the possibility of bacillemia in elderly or immunocompromised OVF patients. Level of Evidence: 4
CONCLUSION: Despite intensive research, the exact origin of the virus and pathophysiology of coronavirus disease is not yet completely known, and clinically approved vaccines and drugs that target severe acute respiratory syndrome coronavirus 2 are lacking. PMID: 32498762 [PubMed - as supplied by publisher]
Authors: Madabhavi I, Sarkar M, Kadakol N Abstract The enduring epidemic outbreak which started in Wuhan city of China, in December 2019 caused by the 2019 novel coronavirus (COVID- 19) or the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has created a dangerous and deadly Public Health disaster of International apprehension, with cases confirmed in several countries. This novel community health trouble is frightening the universe with clinical, psychological, emotional, collapse of health system and economical slowdown in each and every part of the world infecting nearly 200 countries. A highly vir...
We report a 66-year-old female patient with post-mortem diagnosis of COVID-19 who presented progressive livedo racemosa, acute renal failure and myocardial injury, as well as an absence of respiratory symptoms. Transthoracic echocardiography showed severe spontaneous echo contrast in the right cardiac chambers and right-sided cardiac overload presumed to result from pulmonary microvascular thrombosis or embolism.d-dimer levels were increased. The patient developed an acute ischemic stroke and died 2 days following presentation despite therapeutic anticoagulation. Her predominantly thromboembolic presentation supports...
ConclusionsThe use of DPP4 inhibitors, such as gliptins, in patients with COVID-19 with, or even without, type 2 diabetes, may offer a simple way to reduce the virus entry and replication into the airways and to hamper the sustained cytokine storm and inflammation within the lung in patients diagnosed with COVID-19 infection.
ConclusionsOne of the most important roles of otolaryngologists when encountering airway-related signs and symptoms in patients with previous ICU hospitalization for COVID-19 is to maintain a high level of suspicion for LTS development, and share it with colleagues and other health care professionals. Such a condition requires specific expertise and should be comprehensively managed in tertiary referral centers.
ConclusionsIGU is effective for RA, especially with concomitant MTX, and in elderly and male patients.Key Points•Iguratimod is effective for RA, especially with concomitant MTX, and in elderly and male patients.•Since all serious adverse events were in the elderly group in this study, sufficient monitoring for adverse events, especially for elderly RA patients, is needed during iguratimod therapy.
FRIDAY, June 5, 2020 -- For patients with hip fracture, receipt of nitrogen-containing bisphosphonates (N-BPs) is associated with a lower risk for pneumonia and pneumonia mortality, according to a study published online June 2 in the Journal of Bone...
Conditions: Pneumonia, Viral; Corona Virus Infection Intervention: Biological: Anti-coronavirus antibodies (immunoglobulins) obtained with DFPP form convalescent patients Sponsors: Piero Luigi Ruggenenti; Aferetica Not yet recruiting